The UK-China Health and Economy Partnership

This is a novel knowledge transfer partnership between both countries and the partner institutions. The University of Leeds who are partnered with Zhejiang University, Hangzou are working in collaboration with Bournemouth University, University of York, University of Sheffield in the UK and Fudan University and Shandong University in China.


Uk china

Health Economics of Diagnostic Tests and Screening Programmes Masterclass

23rd & 24th March 2021

The University of Leeds and Zhejiang University masterclass will take place in person at Zhejiang University and online throughout China and the UK.

Attendance is by invitation only and all materials will be available online.

UK-CHEP short summary

The UK-China Health and Economy Partnership is a novel knowledge transfer partnership that will promote long-term collaboration between University of Leeds, Bournemouth University, University of York and University of Sheffield in the UK and Zhejiang UniversityFudan University and Shandong University in China.

The partnership aims to create long-term, sustainable collaboration in health economics, which will give UK and Chinese academics the means to work together on world-class educational and research outcomes that would otherwise not be possible working in isolation.

This partnership was originally launched in Jinan, Shandong province in November 2017 by Bournemouth University. GlaxoSmithKline and the British Council have extended the partnership for a further two years, from January 2019.

Read more about the partnership.

Masterclass Summary

The masterclass will explore the key health economic arguments surrounding the implementation of diagnostic tools and screening programmes, demonstrating how concepts of sensitivity and specificity and prevalence fit within the internationally recognised economic evaluation framework used for more traditional treatments.

Presentations will be given by leading experts in health economics and diagnostic and screening evaluation methodologies and the sessions will be chaired by Partnership Leads, Professors Hengjin Dong (Zhejiang University) and Chris Bojke (University of Leeds).

The presenters are:

 

Speaker Biographies

Professor Bojke is the University of Leeds UK lead for the UK-CHEP.  He is a professor in
Bojke chrisProfessor Bojke is the University of Leeds UK lead for the UK-CHEP.  He is a professor in economic evaluation and health technology assessment methods with a speciality using Real World Data.  Chris currently leads the Academic Unit of Health Economics at Leeds and is interim deputy chair of the NICE Public Health Advisory Committee B.
 
Dr Shinkins is an Associate Professor of economic evaluation and health technology
Bethany shinkinsassessment and leads the Test Evaluation Group (TEG) at the University of Leeds. Bethany is also the Deputy Director of the NIHR Leeds In Vitro Diagnostics Co-operative, leading the methodology platform and working closely with industry and academic partners to improve the quality of evidence generation for in vitro diagnostic tests.
 
Dr Smith is a Lecturer in Health Economics and a member of the TEG at the University

Alison Smithof Leeds. Alison recently finished her PhD, in which she explored the role of test measurement uncertainty (bias and imprecision) on the clinical and cost-effectiveness of testing strategies. She sits on the NIHR Leeds In Vitro Diagnostics Co-operative, and is an expert member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Test Evaluation Working Group.

Gill Caldicott
Gill is the Director of the British Council in East China, with responsibility for leading the UK’s cultural relations and educational exchange work in the three Eastern provinces of Anhui, Jiangsu and Zhejiang, as well as Shanghai Municipality. She holds the diplomatic rank of Consul where she manages the UK’s education and cultural relationship on behalf of the British Consulate General Shanghai.
 
Jenny Wu
Jenny Wu is the Head of Corporate Affairs of GlaxoSmithKline (China) Investment Co., Ltd. Jenny has over 17 years’ working experience in healthcare industry. Prior to joining GSK, Jenny had extensive working experience in the United States and Australia.
 
Min Li
Li Min, associate professor, has been serving as director of Zhejiang University’s Office of Global Engagement since November 2016. She oversees ZJU’s global strategy and outreach. Her responsibilities include developing collaborative relations with international partners, in terms of facilitating mobility, promoting joint research and developing overarching framework for university collaboration.
 
Professor Baines is a health economist who specialises in health policy and the
Darrin baines at Bournemouth Universityevaluation of health systems. He has published widely in international journal and is currently the coordinating lead of the UK-China Health and Economy Partnership. Professor Baines is also the academic lead of a British Council funded Newton project currently transferring health economics expertise to pharmacists in Egypt. Visit his website.
 
Professor Dong is the Zhejiang University China lead for the UK-CHEP. He is a professor in health technology assessment and health economics. Professor Dong is also the director of Centre for Health Policy Studies in ZJU and member of the editorial board of PharmacoEconomics, Section Editor of BMC Health Services Research.
 
Professor Gu specialises in health economics, health technology assessment, health behaviour and quality of life assessment. She has published ten articles as first author in international journal such as BMC Medicine, Diabetes Obesity & Metabolism, Pharmacoeconomics, Quality of Life Research, etc., and is currently working in School of Government, Nanjing University. Visit her website.
 
Associate Prof. Xuemei Zhen
Xuemei Zhen is an associate researcher of centre for health management and policy research, Shandong University. She specializes in health economics, health policy, health education, and antimicrobial resistance.
 
Dr Wu is currently a PhD student studying health economics at Zhejiang University in Hangzhou. Wu obtained the bachelor's degree and master's degree from Hebei University and Fudan University, respectively. So far, Wu have published articles in Pharmacol Res (IF=5.9) and Ther Adv Med Oncol (IF=6.8).
 
Dr Zixuan Zhao
Dr Zhao is a PhD student supervised by professor Dong in Zhejiang University. She obtained the bachelor's degree of business management in Hohai University in 2017.She was a co-applicant on three successful bids for economic evaluation program on lung cancer treatment and screening (2019-21).
 
Dr Sun is a PhD. student in School of public health, Zhejiang University. She is currently studying economic modelling and health policy evaluation. Her major studying field is now the economic evaluation of osteoarthritis in China.
 

Download the full event programme document

 

Masterclass Timetable

23 March 2021 - Day 1

China time

UK time

Title

Presenter

15:20

 

08:20

Welcome

Gill Caldicott, British Council;

Jenny Wu, GlaxoSmithKline (China);

Dr, Min Li, International Cooperation, Zhejiang University; Prof Darrin Baines, Bournemouth University;

Prof Hengjin Dong, Zhejiang University

15:40

08:40

Introduction to the Economic Evaluation of Tests

Prof Chris Bojke, University of Leeds

16:40

09:40

Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis

Prof Shuyan Gu, Nanjing University

17:20

10:20

Coffee break

 

17:30

10:30

Economic evaluation of Esophageal cancer screening in China

Prof Hengjin Dong. Zhejiang University

18:00

11:00

Discussion

Lead by Prof Hengjin Dong, Zhejiang University

18:10

11:10

Summary

Prof Chris Bojke University of Leeds

18:30

11:30

Dinner

 

 

24 March 2021 - Day 2

 

 

China time

UK time

Title

Presenter

09:30

02:30

Welcome

Prof Hengjin Dong, Zhejiang University

09:40

 

02:40

Decision analytic models for tests

Dr. Alison Smith

University of Leeds

10:20

03:20

Decision modeling for economic evaluation for CAR-T cell therapy products

Dr. Weijia Wu, Zhejiang University

10:50

03:50

Coffee break

 

11:00

04:00

Public preferences on lung cancer screening in rural China

Dr. Zixuan Zhao, Zhejiang University

11:30

04:30

Discussion

Lead by Prof Hengjin Dong, Zhejiang University

11:40

04:40

Dinner

 

15:00

08:00

Economic burden of antibiotic resistance in China: a national level estimate for inpatients

Dr. Xuemei Zhen, Shandong University

15:30

08:30

Welcome

Prof Chris Bojke University of Leeds

15:40

 

08:40

Thinking beyond accuracy

Dr. Bethany Shinkins

University of Leeds

16:30

09:30

Coffee break

 

16:40

09:40

Cost effectiveness of drugs managing osteoarthritis in China

Dr. Xueshan Sun, Zhejiang University

17:20

10:20

Discussion

Lead by Bethany Shinkins, University of Leeds

18:00

11:00

Summary

Prof Chris Bojke University of Leeds

Prof Hengjin Dong,

Zhejiang University

18:20

11:20

Dinner